The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin today.
from NDTV News - Topstories https://ift.tt/2FN96yE
Subscribe to:
Post Comments (Atom)
'No settlement without backing of Byju's creditors'
The National Company Law Appellate Tribunal (NCLAT) has dismissed attempts to halt insolvency proceedings against Byju's without credito...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News http://bit.ly/2VEK8DU...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
No comments:
Post a Comment